Last week, our Chief Scientific Officer @MilesCcc participated in @BioCentury Grand Rounds Europe in Cambridge, UK. During his "Small Compounds, Big Potential" panel, Miles discussed how technology is accelerating and reducing the cost of molecule creation, and the collaborative efforts of academia, start-ups, and industry in advancing drug development. ...

Event Announcement - The company's Chief Technology Officer, Sergei Iakhnin, will be a keynote speaker at BioTechX EU Congress on October 6th at 9am CEST [1] - The keynote will focus on the application of AI in understanding and solving diseases [1] AI & Biotechnology - The company aims to use AI to accelerate breakthroughs in disease research [1] - The company envisions a future where AI can help solve all diseases [1]

Drug Development & AI - Isomorphic Labs is using AI models to tackle challenging diseases, including cancers [1] - The company has a generalisable drug design engine to tackle a range of different cancers [1] Company Strategy - Isomorphic Labs aims to tackle multiple cancers rather than focusing on one program at a time [1]

General Information - The document provides a link to a resource, potentially a video or webpage [1]

Drug Discovery Timeline - Isomorphic Labs的目标是将药物发现的时间从几年缩短到几个月，甚至更快[1][2] - Demis Hassabis认为，随着Isomorphic Labs的平台在未来几年内成熟，这一目标是可能实现的[1] AI's Role in Drug Discovery - AI技术的进步可能将药物发现的时间大大缩短[2] - Isomorphic Labs正在利用统一的药物设计引擎，加速药物开发，并寻找解决世界最具挑战性疾病的方法[1] Isomorphic Labs' Mission - Isomorphic Labs的使命是利用AI技术攻克癌症[2] - Isomorphic Labs致力于更快地将药物送到患者手中[1]

Company Focus - DeepMind is leveraging frontier AI to reimagine drug discovery and advance human health [1] - DeepMind's Iso project aims to solve all diseases [1] Leadership Engagement - DeepMind's CEO, Chief AI Officer, and Head of Medicinal Drug Design were featured on Bloomberg Tech Europe to discuss AI in drug discovery [1]

Team & Technology - The company's DMPK team utilizes state-of-the-art AI models to deliver promising clinical candidates [1] - The team's work is varied, interdisciplinary, and spans multiple modalities [1] Career Opportunities - Opportunities exist to join the DMPK team [1] - More information about joining the team can be found on the company website [1]

Company Information - MilesCcc接受TIME采访，具体内容请参考提供的链接 [1]

Achievements & Recognition - The company's Chief Scientific Officer, MilesCcc, has been featured in the TIME 100 AI list, highlighting the company's prominence in the AI field [1] AI Drug Discovery - The company is developing a generalizable AI drug design engine [1] - The company is tackling drug targets that have long been considered too difficult to pursue, showcasing its innovative approach [1]

Key Advice - Start with a fundamental question [1] - Have the courage to do things "you've no idea how to do" [1] - Visualize molecules in the mind's eye as a starting point to find novel solutions [1] Inspiration - Sir David inspired the audience [1]